Takeda Pharmaceutical Company Limited Weighted Average Duration Of Defined Benefit Obligation
Takeda Pharmaceutical Company Limited (TKPHF) reported Weighted Average Duration Of Defined Benefit Obligation of 15.2 year for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-27.
Discontinued › Income Statement
ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation · last filed 2019-06-27
| Period end | Weighted Average Duration Of Defined Benefit Obligation 12 month |
|---|---|
| 2019-03-31 | 15.20 year 20-F · filed 2019-06-27 |
| 2018-03-31 | 14.40 year 20-F · filed 2019-06-27 |